Tag Archives: US govt awards Novavax $1.6 billion for coronavirus vaccine

CHICAGO: The US government has awarded Novavax $1.6 billion to cover testing, commercialization and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021. The award is the biggest yet from “Operation Warp Speed”, the White House program aimed at accelerating access to vaccines and treatments to fight the …

Read More »